Los Angeles, CA, United States of America

Boris A Kashemirov

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Venice, CA (US) (1999)
  • Los Angeles, CA (US) (2008 - 2022)

Company Filing History:


Years Active: 1999-2022

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: **Boris A Kashemirov: Innovator in Drug Conjugates and Imaging Technology**

Introduction

Boris A Kashemirov, an accomplished inventor based in Los Angeles, California, has made significant contributions to the fields of pharmaceuticals and biomedical imaging. With a portfolio of 12 patents, his work focuses on innovative solutions for treating diseases, particularly in the ear, and advancing imaging techniques for osteoclast activity.

Latest Patents

Among his latest innovations is the development of phosphonate-drug conjugates. This invention specifically targets localized treatment of diseases or disorders of the middle and inner ear. It includes methods for treating these conditions, pharmaceutical compositions incorporating the conjugates, and strategies for inhibiting Tropomyosin receptor kinase. Additionally, Kashemirov has introduced osteoadsorptive fluorogenic substrates of cathepsin K for imaging osteoclast activity and migration. These substrates utilize a bisphosphonate targeting moiety that allows for prolonged monitoring of resorption activity with a single dose, making them more effective than existing probes.

Career Highlights

Boris A Kashemirov's career is marked by significant roles at renowned institutions and companies. He has worked at the University of Southern California, where he contributed to innovative research in pharmaceuticals. Additionally, he was involved with Tsrl, Inc., a company dedicated to advancing technologies in therapeutic applications. His inventive spirit is exemplified by his numerous patents that push the boundaries of current medical practices.

Collaborations

Collaboration has played a pivotal role in Kashemirov's work. He has partnered with esteemed colleagues such as Charles E McKenna and John Hilfinger, both of whom have contributed to the advancement of research within their respective fields. These partnerships have fostered an environment of shared knowledge and innovation, leading to the development of cutting-edge medical solutions.

Conclusion

Boris A Kashemirov stands out as a vital contributor to the landscape of pharmaceutical innovation and biomedical imaging. His inventive work continues to shape the treatment of ear disorders and enhances our understanding of bone-related diseases. With a robust patent portfolio and an impressive career trajectory, Kashemirov remains a significant figure in the realm of scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…